[1]
Mahmud, H., Hai, A.N.M.A. and Ahammod, T. 2022. Effect of spironolactone with angiotensin receptor blocker on albuminuria in type 2 diabetic patients with nephropathy. International Journal of Advances in Medicine. 9, 4 (Mar. 2022), 393–398. DOI:https://doi.org/10.18203/2349-3933.ijam20220775.